Products

BioticsAI
BioticsAI, Inc.
OB/GYN AI
BioticsAI is an AI-powered software that enhances prenatal ultrasound screenings by validating quality, detecting anomalies, and automating report generation, empowering obstetricians and improving patient care.

See all 1 product →

About BioticsAI

BioticsAI is a healthcare AI company dedicated to revolutionizing fetal and maternal ultrasound screening through advanced artificial intelligence. The company’s AI-powered software is designed to significantly reduce diagnostic errors, which are a critical concern given that a substantial portion of fetal malformations are misdiagnosed due to inconsistencies in ultrasound procedures. For obstetricians and prenatal care providers, BioticsAI offers a robust platform that performs automated image quality assessment, identifies anatomical views, detects abnormalities, and generates comprehensive reports.

This innovative solution acts as a “co-pilot” during and after ultrasound examinations, providing real-time feedback to clinicians. It validates the completeness of screenings, localizes problematic anatomical views, and automates documentation, thereby mitigating operator dependency and enhancing diagnostic accuracy. By streamlining these processes, BioticsAI aims to free up valuable time for healthcare professionals, allowing them to focus more on patient care and ensuring that every expectant mother receives a diagnostically viable and safe screening, ultimately improving prenatal care outcomes globally.

The company’s technology is built on a foundation of millions of prenatal images, utilizing complex computer vision models that meet stringent regulatory requirements, including FDA clearance for its AI software to detect fetal abnormalities in ultrasound images. BioticsAI’s long-term vision extends to becoming the leading AI diagnostics platform for reproductive health, with plans to expand its capabilities into adjacent specialties such as gynecology, urology, and neonatology.

Focus Areas

AI-powered fetal ultrasound prenatal care fetal anomaly detection ultrasound quality assurance automated medical reporting reproductive health diagnostics computer vision in healthcare

Business Intelligence

Key InvestorsTechstars, Gurtin Ventures, Startup Battlefield, Startmate, StartUp Health
PartnershipsInitial contracts with three academic medical centers and five community hospitals (slated for Q2 2026), rolling out in Australian hospitals, collaborations with Duke University, Stanford, and Charlotte's AI4Health Center
TechnologyCloud-native, computer vision algorithms, machine learning, integrates with EHR, PACS, and HIS systems, utilizes Label Studio Enterprise for data annotation, SaaS-based platform
FDA Clearances1 cleared products (estimated)

What Physicians Need to Know

AI-powered Fetal Ultrasound & Anomaly Detection
BioticsAI specializes in integrating artificial intelligence with ultrasound imaging technology to detect and diagnose fetal abnormalities in unborn babies. Their core mission is to tackle the high rate of misdiagnosis, which can be up to 50% for fetal malformations. The platform provides real-time quality assessment of fetal ultrasound images, automated detection of anatomical landmarks to ensure completeness, and localization of problematic anatomical views. Their models are trained on millions of prenatal images, including diverse demographics, demonstrating over 95% sensitivity for detecting major fetal anomalies.
Prenatal Care & Ultrasound Quality Assurance
The company addresses the global skills shortage in obstetrics and sonography by providing an AI-powered safety net that removes the variable of operator dependency. BioticsAI standardizes image acquisition through real-time feedback to sonographers, ensuring that all necessary anatomical views (over 90 different structures) are captured and meet minimum quality criteria. This ensures every patient receives a diagnostically viable and safe screening, improving the overall quality of prenatal care.
Automated Medical Reporting
BioticsAI automates the generation of structured preliminary reports for clinicians by extracting key measurement data and seamlessly integrating with clinical workflows. This significantly reduces the administrative burden on medical staff, saving up to eight minutes per patient on documentation and allowing physicians to prioritize patient well-being.
Reproductive Health Diagnostics & Computer Vision
Leveraging advanced computer vision and machine learning algorithms, BioticsAI aims to become the 'AI diagnostics platform for reproductive health.' While currently focused on obstetrics and second-trimester anomaly screenings, their vision includes expanding into adjacent specialties such as gynecology, urology, and neonatology. Their technology is built on a continuously growing proprietary dataset of ultrasound images, enabling the development of new algorithms for various indications.
Physician Tip

For physicians, BioticsAI acts as an intelligent 'co-pilot,' providing an AI-powered safety net and a second opinion during fetal ultrasound screenings. This empowers you with increased confidence in every exam, drastically reducing the chances of misdiagnosis and ensuring consistent, high-quality care for all patients, regardless of sonographer experience. The automated reporting significantly streamlines your workflow, freeing up valuable time from administrative tasks to focus on patient interaction and critical decision-making. Furthermore, the FDA clearance provides a strong assurance of the technology's reliability and safety, making it a trustworthy tool to enhance prenatal outcomes and address health disparities.

BioticsAI is designed as a vendor-agnostic, cloud-based software solution that seamlessly integrates with existing ultrasound machines (e.g., GE Medical, Samsung, Canon, Philips) over standard APIs. It offers plug-and-play integration with hospital Picture Archiving and Communication Systems (PACS) and Electronic Medical Record (EMR) systems, ensuring a smooth transition into current clinical workflows without extensive re-engineering.

Products by BioticsAI

1 product in the directory

BioticsAI
BioticsAI, Inc.
OB/GYN AI
BioticsAI is an AI-powered software that enhances prenatal ultrasound screenings by validating quality, detecting anomalies, and automating report generation, empowering obstetricians and improving patient care.

What the Web Says

BioticsAI appears to be a relatively new or niche company, as there is very limited public information and reviews available across major platforms like G2, Glassdoor, Capterra, and Reddit. Specific product or employer reviews are not readily found, making it difficult to form a comprehensive opinion.

Overall: Mixed

Strengths

  • Information not available
  • Unknown
  • Unknown
  • Unknown
  • Unknown
  • Unknown

Limitations

  • Lack of public reviews and information
  • Limited online presence
  • Difficulty in assessing product effectiveness
  • Difficulty in assessing company culture or employee satisfaction
  • Unknown
  • Unknown

Based on reviews from: G2, Glassdoor, Capterra, Reddit, General web search for healthcare IT reviews

Last updated: 2026-07-17

Videos

News, demos, and interviews about BioticsAI.

Loading videos...

Videos load interactively. If none appear, search YouTube for BioticsAI →

View all on YouTube

Press & Coverage

Cyprus Business Group
BioticsAI Secures FDA Approval for AI-Powered Fetal Ultrasound After 2023 Disrupt Battlefield Win
BioticsAI, winner of TechCrunch Disrupt Battlefield 2023, has received U.S. Food and Drug Administration (FDA) clearance for its AI software designed to assist in detecting fetal abnormalities through ultrasound imaging. This marks a significant step towards large-scale clinical deployment for the healthtech startup.
2026-01
Reddit (r/ai_news_byte_sized)
FDA Clears BioticsAI's AI-Powered Fetal Ultrasound System : r/ai_news_byte_sized
BioticsAI's AI-assisted fetal ultrasound analysis system has received full FDA clearance, aiming to standardize detection accuracy across different clinicians and imaging environments. This approval signifies continued regulatory acceptance for AI diagnostic tools in healthcare.
2026-01
TechCrunch
TechCrunch: BioticsAI, gains FDA clearance for its AI-powered fetal ultrasound product
BioticsAI has received FDA 510(k) clearance for its comprehensive AI-driven fetal anatomy tool for routine midtrimester anatomy examinations, becoming the first US-founded company to achieve this for standard midtrimester fetal ultrasound examinations.
2026-01
AI NEWS
AI Protects the First Life: BioticsAI Receives FDA Approval to Accurately Address Fetal Misdiagnosis Challenges
BioticsAI, the winner of the 2023 TechCrunch Disrupt competition, announced FDA approval for its AI software that helps doctors detect fetal abnormalities in ultrasound images, significantly improving prenatal screening accuracy. The technology uses advanced computer vision algorithms for quality assessment, anatomical integrity checks, and automated report generation.
2026-01
FindArticles
BioticsAI Wins FDA Clearance For Fetal Ultrasound AI
BioticsAI has secured U.S. Food and Drug Administration clearance for its AI software that assists clinicians during fetal ultrasound exams, marking a significant advancement for AI in routine prenatal care. The system aims to reduce missed views, standardize measurements, and identify potential concerns in real-time.
2026-01
daily.dev
FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder
BioticsAI CEO Robhy Bustami discusses the company's journey in building an AI copilot for fetal ultrasound detection, winning TechCrunch Startup Battlefield 2023, and securing FDA approval. Key lessons include integrating regulatory strategy from day one and engaging early with the FDA.
2026-04
YouTube (StartUp Health TV)
BioticsAI Boasts High Diagnostic Accuracy in Prenatal Ultrasounds
BioticsAI, a platform for obstetricians, aims to improve prenatal diagnostics by mitigating errors in ultrasound exams and detecting fetal abnormalities. The company, a winner of TechCrunch Disrupt 2023, has shown significant improvements in ultrasound accuracy and workflow efficiency, with 98% diagnostic accuracy.
2024-12
YouTube (TechCrunch)
BioticsAI Pitches at Startup Battlefield | TechCrunch Disrupt 2023
BioticsAI's pitch at TechCrunch Disrupt 2023 highlighted their AI-powered solution to detect fetal abnormalities in ultrasounds, addressing the high rate of misdiagnosis due to operator errors. Their technology aims to improve diagnostic quality and efficiency, and they won the competition.
2023-09

Frequently Asked Questions

BioticsAI utilizes advanced computer vision and machine learning to analyze fetal ultrasound images, providing automated measurements, quality assessment, and flagging potential anomalies for physician review. This technology aims to standardize ultrasound reporting, reduce inter-operator variability, and improve the early detection of critical conditions, thereby enhancing the overall quality of prenatal care.
Our platform is designed for seamless integration with most existing ultrasound machines and EMR systems through standard protocols like DICOM and HL7. This allows for automated image transfer, analysis, and direct population of structured reports into the patient's EMR, minimizing disruption to current clinical workflows and reducing manual data entry.
BioticsAI's algorithms undergo rigorous validation using large, diverse datasets of de-identified ultrasound images, demonstrating high sensitivity and specificity for various fetal anomalies. Our solutions are continuously refined through ongoing clinical studies and collaborations with leading medical institutions to ensure robust performance and reliability in real-world settings.
BioticsAI is committed to achieving and maintaining all necessary regulatory clearances, such as FDA 510(k) and CE Mark, for its diagnostic aids. We adhere strictly to global data privacy regulations like HIPAA and GDPR, employing robust encryption, access controls, and and de-identification protocols to protect patient data throughout our system.
We offer comprehensive training programs for sonographers, physicians, and IT staff to ensure effective implementation and utilization of our platform. Our dedicated support team provides ongoing technical assistance, clinical guidance, and regular software updates to optimize performance and address any user queries promptly.
BioticsAI offers flexible subscription-based pricing models tailored to the volume and specific needs of each healthcare facility. Our solutions aim to provide significant ROI through improved diagnostic accuracy, reduced sonographer scan time, enhanced reporting efficiency, and potentially fewer missed diagnoses leading to better patient outcomes and reduced downstream costs.

Related Companies

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]

allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.